Status:
COMPLETED
Safety and Bioefficacy of Vitamin D2 and Vitamin D3
Lead Sponsor:
Ulrike Lehmann
Conditions:
Vitamin D Deficiency
Eligibility:
All Genders
18-75 years
Phase:
NA
Brief Summary
The aim of this study is to investigate the bioavailability of vitamin D2 and D3 as measured by the increase of the specific hydroxy forms in serum (25(OH)D2 and 25(OH)D3, respectively, and by total 2...
Detailed Description
Study design: Human volunteers will receive supplements containing either vitamin D2 or D3 for a period of 8 weeks. At baseline, after 4 weeks and after 8 weeks, 25(OH)D2, 25(OH)D3 and total 25(OH)D w...
Eligibility Criteria
Inclusion
- 18 years
- healthy
Exclusion
- supplementation of vitamin d and calcium
- hypercalcemia
- hypercalciuria
- chronical illness (diabetes, kidney diseases, cardiovascular diseases)
- serum-creatinine above 115 mmol/l
- pregnancy or breastfeeding women
Key Trial Info
Start Date :
January 1 2012
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
May 1 2012
Estimated Enrollment :
120 Patients enrolled
Trial Details
Trial ID
NCT01503216
Start Date
January 1 2012
End Date
May 1 2012
Last Update
October 10 2012
Active Locations (0)
Enter a location and click search to find clinical trials sorted by distance.
No Results Found
We couldn’t find results for the location/zipcode entered or within the selected range. Please check your input or adjust your search.